Cost-effectiveness analysis of Crohn's disease treatment with vedolizumab and ustekinumab after failure of tumor necrosis factor-$\alpha$ antagonist

Simple view

Full metadata view

Authors

Statistics

Cost-effectiveness analysis of Crohn's disease treatment with vedolizumab and ustekinumab after failure of tumor necrosis factor- antagonist

2018

journal article

article

Journal

PharmacoEconomics

40

Author

Holko Przemysław

Kawalec Paweł

Pilc Andrzej

Volume

36

Issue

7

Pages

853-865

ISSN

1170-7690

eISSN

1179-2027

Language

English

Container language

English

dc.affiliation	Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego	pl
dc.cm.date	2020-01-07
dc.cm.id	88937
dc.contributor.author	Holko, Przemysław	pl
dc.contributor.author	Kawalec, Paweł - 130055	pl
dc.contributor.author	Pilc, Andrzej - 133153	pl
dc.date.accessioned	2020-01-17T09:58:47Z
dc.date.available	2020-01-17T09:58:47Z
dc.date.issued	2018	pl
dc.date.openaccess	0
dc.description.accesstime	w momencie opublikowania
dc.description.number	7	pl
dc.description.physical	853-865	pl
dc.description.points	40	pl
dc.description.version	ostateczna wersja wydawcy
dc.description.volume	36	pl
dc.identifier.doi	10.1007/s40273-018-0653-2	pl
dc.identifier.eissn	1179-2027	pl
dc.identifier.issn	1170-7690	pl
dc.identifier.project	ROD UJ / OP	pl
dc.identifier.uri	https://ruj.uj.edu.pl/xmlui/handle/item/143264
dc.language	eng	pl
dc.language.container	eng	pl
dc.rights	Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa	*
dc.rights.licence	CC-BY-NC
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/legalcode.pl	*
dc.share.type	inne
dc.subtype	Article	pl
dc.title	Cost-effectiveness analysis of Crohn's disease treatment with vedolizumab and ustekinumab after failure of tumor necrosis factor-$\alpha$ antagonist	pl
dc.title.journal	PharmacoEconomics	pl
dc.type	JournalArticle	pl
dspace.entity.type	Publication